GSK: collaborates with Oxford University for cancer vaccine
(CercleFinance.com) - GSK announces a collaboration with the University of Oxford to explore cancer prevention through vaccination as part of the GSK-Oxford Cancer Immuno-Prevention program.
The partnership, backed by a £50m investment over three years, aims to study the biology of precancerous cells and identify vaccine approaches targeting their vulnerabilities to prevent their progression to cancer.
Tony Wood, GSK's Chief Scientific Officer, stressed the importance of this collaboration in developing innovative solutions for people at risk.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
The partnership, backed by a £50m investment over three years, aims to study the biology of precancerous cells and identify vaccine approaches targeting their vulnerabilities to prevent their progression to cancer.
Tony Wood, GSK's Chief Scientific Officer, stressed the importance of this collaboration in developing innovative solutions for people at risk.
Copyright (c) 2025 CercleFinance.com. All rights reserved.